aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure.
Yunqing SunZhuohong LiGuichan LiaoMuye XiaXuwen XuShao-Hang CaiJie PengPublished in: International journal of general medicine (2022)
A higher aMAP score was an independent risk predictor of re-hospitalization, HCC occurrence and mortality, respectively, in HBV-ACLF patients who survived over 6 months, which can be applicable for early risk stratification and clinical decision.